MR. JEFFREY EUGENE MCKINNEY, N.P.
Nursing at Welch Rd, Palo Alto, CA

License number
California 21011
Category
Nursing
Type
Family
Address
Address
750 Welch Rd SUITE 750, Palo Alto, CA 94304
Phone
(650) 724-9640
(650) 498-7888 (Fax)

Professional information

Jeffrey Eugene Mckinney Photo 1

Jeffrey Eugene McKinney, Palo Alto CA

Specialties:
Nurse Practitioner
Address:
750 Welch Rd, Palo Alto, CA 94304
300 Pasteur Dr, Stanford, CA 94305
350 Parnassus Ave, San Francisco, CA 94117


Jeffrey Mckinney Photo 2

Pyridazino Quinoline Compounds

US Patent:
6232313, May 15, 2001
Filed:
Mar 19, 1998
Appl. No.:
9/044109
Inventors:
Thomas Michael Bare - West Chester PA
Timothy Wayne Davenport - New Castle DE
James Roy Empfield - Bear DE
Jeffrey Alan McKinney - Palo Alto CA
Richard Bruce Sparks - Linwood PA
Assignee:
Zeneca Limited
International Classification:
A61K 315025, C07D47104
US Classification:
514248
Abstract:
The present invention relates to compounds, pharmaceutical compositions and methods of using compounds having the formula below ##STR1## in the treatment and prevention of certain diseases or conditions. Where the ring designated A is chosen from ortho substituted aryl or heteroaryl species, R. sup. 1 and R. sup. 2 are chosen independently from --(CH. sub. 2). sub. n L where L is selected from a variety of substituents including hydrogen, and aryl, heteroaryl or heterocyclic groups and R. sup. 4 is chosen from a variety of substituents including halogen and alkyl groups. The compounds are useful in treating and preventing neurological disorders associated with excitatory amino acids.


Jeffrey Mckinney Photo 3

Pyridazino Quinoline Compounds

US Patent:
6214826, Apr 10, 2001
Filed:
Aug 2, 1999
Appl. No.:
9/365562
Inventors:
Thomas Michael Bare - West Chester PA
Marc Jerome Chapdelaine - Wilmington DE
Timothy Wayne Davenport - Wilmington DE
James Roy Empfield - Bear DE
Paul Francis Jackson - Bel Air MD
Jeffrey Alan McKinney - Palo Alto CA
Charles David McLaren - Landenberg PA
Richard Bruce Sparks - Boothwyn PA
Assignee:
Zeneca Limited
International Classification:
A61K 315025, C07D47104
US Classification:
514248
Abstract:
The invention relates to pyridazinoquinoline compounds of the formulas B and B' ##STR1## wherein Ring A is selected from an ortho fused aromatic or heteroaromatic five- or six-membered ring and R. sup. 1, R. sup. 3 and R. sup. 4 are substituents selected from halo, OH, OCF. sub. 3, NO. sub. 2, CN, NR'R", SO. sub. 2 NR'R", SO. sub. m R'alkyl, and a variety of alkyl, aryl, heterocyclic and heteroaryl groups, to pharmaceutical compositions containing them and to methods utilizing them for the treatment of neurological disorders.


Jeffrey Mckinney Photo 4

Heteroaryl-Substituted Pyridazino Quinoline Compounds

US Patent:
6103721, Aug 15, 2000
Filed:
Dec 6, 1999
Appl. No.:
9/455096
Inventors:
Thomas Michael Bare - West Chester PA
Timothy Wayne Davenport - New Castle DE
James Roy Empfield - Bear DE
Jeffrey Alan McKinney - Palo Alto CA
Richard Bruce Sparks - Linwood PA
Assignee:
Zeneca Limited
International Classification:
A61K 315025, C07D47104
US Classification:
514248
Abstract:
The present invention concerns compounds according to the following formula, ##STR1## wherein: R. sup. 1 is (CH. sub. 2). sub. n,L where n is an integer in the range 0 to 6, and L is a carbon-linked five-membered heteroaryl ring having an oxygen or sulfur heteroatom, R. sup. 4 is hydrogen, halo or NO. sub. 2, and pharmaceutical compositions and methods of using thereof in the treatment and/or prevention of neurological diseases or conditions.


Jeffrey Mckinney Photo 5

Pyridazion Quinoline Compounds

US Patent:
5744471, Apr 28, 1998
Filed:
Apr 17, 1996
Appl. No.:
8/637641
Inventors:
Thomas Michael Bare - West Chester PA
Timothy Wayne Davenport - New Castle DE
James Roy Empfield - Bear DE
Jeffrey Alan McKinney - Palo Alto CA
Richard Bruce Sparks - Linwood PA
Assignee:
Zeneca Limited - London
International Classification:
A61K 3150, C07D47104, C07D47114, C07D49114
US Classification:
514248
Abstract:
The present invention relates to compounds, pharmaceutical compositions and methods of using compounds of formula (I) in the treatment and/or prevention of certain diseases or conditions. In formula (I), A is chosen from ortho substituted aryl or heteroaryl species, X is chosen from --OH, --SH, NHR and R. sup. 1 or R. sup. 2 is chosen from --(CH. sub. 2). sub. n L wherein L may be selected from a variety of substituents including aryl, heteroaryl and heterocyclic groups. The compounds are useful in treating and/or preventing neurological disorders associated with excitatory amino acids. ##STR1##.